NASDAQ:SPRO
Spero Therapeutics
- Stock
Last Close
1.37
30/08 20:00
Market Cap
73.42M
Beta: 0.87
Volume Today
58.38K
Avg: 603.93K
PE Ratio
−115.83
PFCF: 2.64
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 335K - | 1.98M 490.75% | 3.97M 100.40% | 4.74M 19.57% | 9.33M 96.75% | 18.26M 95.67% | 48.58M 166.10% | 96.73M 99.13% | ||
cost of revenue | 65.78M - | 67.00M 1.87% | 1.12M 98.33% | 1.55M 38.50% | 367K 76.28% | |||||
gross profit | 335K - | 1.98M 490.75% | 3.97M 100.40% | -61.03M 1,638.91% | -57.67M 5.51% | 17.14M 129.72% | 47.03M 174.42% | 96.37M 104.90% | ||
selling and marketing expenses | ||||||||||
general and administrative expenses | 2.20M - | 7.22M 228.02% | 10.84M 50.08% | 12.89M 18.88% | 15.59M 20.96% | 21.44M 37.54% | 41.70M 94.50% | 36.48M 12.51% | 25.55M 29.96% | |
selling general and administrative expenses | 2.20M - | 7.22M 228.02% | 10.84M 50.08% | 12.89M 18.88% | 15.59M 20.96% | 21.44M 37.54% | 41.70M 94.50% | 36.48M 12.51% | 25.55M 29.96% | |
research and development expenses | 11.13M - | 26.33M 136.70% | 32.87M 24.82% | 33.88M 3.09% | 65.78M 94.11% | 67.00M 1.87% | 64.53M 3.70% | 47.59M 26.24% | 51.07M 7.31% | |
other expenses | 174K - | -4.37M - | 1.14M 126.20% | -13.40M 1,271.77% | 833K 106.21% | -395K 147.42% | -4.93M 1,148.10% | -14K 99.72% | ||
cost and expenses | 13.33M - | 33.56M 151.79% | 41.73M 24.36% | 42.81M 2.58% | 67.96M 58.76% | 88.44M 30.14% | 106.23M 20.11% | 79.15M 25.49% | 76.99M 2.72% | |
operating expenses | 13.33M - | 33.56M 151.79% | 41.73M 24.36% | 42.81M 2.58% | 67.96M 58.76% | 88.44M 30.14% | 106.23M 20.11% | 79.15M 25.49% | 76.63M 3.18% | |
interest expense | 303K - | 303K 0% | 1.94M - | 2.60M 34.28% | ||||||
ebitda | -13.49M - | -33.52M 148.50% | -41.73M 24.49% | -42.81M 2.58% | -63.22M 47.68% | -79.11M 25.15% | -87.37M 10.44% | -18.94M 78.33% | 20.11M 206.18% | |
operating income | -13.33M - | -33.22M 149.28% | -41.73M 25.61% | -42.81M 2.58% | -63.22M 47.68% | -79.11M 25.15% | -87.97M 11.20% | -42.20M 52.03% | 19.74M 146.78% | |
depreciation and amortization | 11K - | 279K 2,436.36% | 363K 30.11% | 409K 12.67% | 750K 83.37% | 761K 1.47% | 597K 21.55% | 23.26M 3,796.15% | 367K 98.42% | |
total other income expenses net | 174K - | 580K 233.33% | -4.37M 852.93% | 1.14M 126.20% | 2.29M 100.26% | 833K 63.64% | -1.78M 314.29% | -4.22M 136.30% | 5.66M 234.26% | |
income before tax | -13.15M - | -32.64M 148.16% | -46.10M 41.22% | -41.66M 9.62% | -60.92M 46.24% | -78.28M 28.49% | -89.76M 14.66% | -46.41M 48.29% | 25.40M 154.73% | |
income tax expense | -3.17M - | -7.73M 143.62% | -363K 95.30% | 1.14M 415.15% | -750K 165.56% | -761K 1.47% | 1.54M 303.02% | 1.61M 4.40% | 2.60M 61.07% | |
net income | -10.15M - | -25.49M 151.04% | -46.10M 80.84% | -41.66M 9.62% | -60.17M 44.44% | -77.52M 28.82% | -91.30M 17.78% | -48.03M 47.40% | 22.81M 147.48% | |
weighted average shs out | 6.60M - | 6.60M 0% | 2.59M 60.83% | 16.00M 518.58% | 18.16M 13.49% | 22.39M 23.27% | 30.90M 38.01% | 37.59M 21.65% | 52.70M 40.22% | |
weighted average shs out dil | 6.60M - | 6.60M 0% | 2.59M 60.83% | 16.00M 518.58% | 18.16M 13.49% | 22.39M 23.27% | 30.90M 38.01% | 37.59M 21.65% | 52.99M 40.98% | |
eps | -1.54 - | -3.86 150.65% | -17.82 361.66% | -2.60 85.41% | -3.31 27.31% | -3.46 4.53% | -2.96 14.45% | -1.28 56.76% | 0.43 133.59% | |
epsdiluted | -1.54 - | -3.86 150.65% | -17.82 361.66% | -2.60 85.41% | -3.31 27.31% | -3.46 4.53% | -2.96 14.45% | -1.28 56.76% | 0.43 133.59% |
All numbers in USD (except ratios and percentages)